This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20170110 US Realm SC Call"
Jump to navigation
Jump to search
(Created page with "{{subst:: US Realm TF Template}}") |
|||
| Line 15: | Line 15: | ||
'''Location: '''call 770-657-9270 using code 156896#<br/> [https://global.gotomeeting.com/join/929752237 929-752-237] | '''Location: '''call 770-657-9270 using code 156896#<br/> [https://global.gotomeeting.com/join/929752237 929-752-237] | ||
| − | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: | + | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2017-01-10'''<br/> '''Time: 1 PM Eastern''' |
|- | |- | ||
| colspan="1" align="right"|'''Co-Chairs''' | | colspan="1" align="right"|'''Co-Chairs''' | ||
| Line 74: | Line 74: | ||
Administrivia | Administrivia | ||
*Agenda review | *Agenda review | ||
| − | *Review notes from [[ | + | *Review notes from [[20161206_US_Realm_SC_Call]] |
| − | * | + | *Review Items: |
| − | + | **Newborn Dried Blood Spot Screening Lab Order Component/ Implementation Guide | |
| − | Discussion: | + | *Discussion: |
| − | * | + | **Do we want to expand the scope of the FHIR US-Core? What is the process? |
| − | + | **What US Realm FHIR IGs are we tracking? (this should probably be a recurring agenda item) | |
| + | **Who is providing coordination among those IGs? | ||
| + | **Do we want to develop a list of principles for developing US Realm FHIR IGs? | ||
| + | ***Reuse us-core | ||
| + | ***Follow us realm extension development process | ||
| + | ***Quality criteria (see example SDWG use for C-CDA) | ||
===Minutes=== | ===Minutes=== | ||
| Line 114: | Line 119: | ||
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | |width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | ||
| − | *[[ | + | *[[20170131 US Realm SC Call]] Tuesday at 1 PM ET |
|} | |} | ||
Revision as of 14:54, 10 January 2017
back to US_Realm_Steering_Committee
back to US_Realm_Steering_Committee_Conference_Calls
| US Realm Steering Committee Call Agenda/Minutes Location: call 770-657-9270 using code 156896# |
Date: 2017-01-10 Time: 1 PM Eastern | ||
| Co-Chairs | Ed/Brett | Note taker(s) | Anne |
| Attendee / Name | |||||||||||
| Calvin Beebe | Keith Boone | Hans Buitendijk | |||||||||
| Lorraine Constable | Johnathan Coleman | Ed Hammond | |||||||||
| Tony Julian | Paul Knapp | Austin Kreisler | |||||||||
| Brett Marquard | Ken McCaslin | Nancy Orvis | |||||||||
| Brian Pech | Wayne Kubick | Mark Roche | |||||||||
| Sandra Stuart | . | Pat Van Dyke | . | Anne Wizauer | |||||||
| Danielle Friend | . | Eric Haas | . | Jenni Syed | |||||||
| Steve Posnak | . | David Susanto | . | Visitor / Name | |||||||
| no quorum definition | |||||||||||
Agenda
Administrivia
- Agenda review
- Review notes from 20161206_US_Realm_SC_Call
- Review Items:
- Newborn Dried Blood Spot Screening Lab Order Component/ Implementation Guide
- Discussion:
- Do we want to expand the scope of the FHIR US-Core? What is the process?
- What US Realm FHIR IGs are we tracking? (this should probably be a recurring agenda item)
- Who is providing coordination among those IGs?
- Do we want to develop a list of principles for developing US Realm FHIR IGs?
- Reuse us-core
- Follow us realm extension development process
- Quality criteria (see example SDWG use for C-CDA)
Minutes
Meeting Outcomes
| Actions
|
Next Meeting/Preliminary Agenda Items
|
© 2016 Health Level Seven® International. All rights reserved
